GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd (SZSE:300937) » Definitions » Research & Development

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Research & Development : ¥19 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Research & Development for the three months ended in Mar. 2024 was ¥5 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥19 Mil.


Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Research & Development Historical Data

The historical data trend for Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Research & Development Chart

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial - - 11.38 17.71 19.32

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.67 4.55 4.90 5.20 4.80

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥19 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co  (SZSE:300937) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Youlian 1st Street, 13th Floor, Jinniu District, Sichuan Province, Chengdu, CHN, 610081
Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co Ltd provides convenient, efficient and low-cost medical circulation services for the vast community medical terminals and primary medical institutions. It offers various products such as respiratory system, cardiovascular and neurological drugs, biological product, rheumatism and bone injuries and other medicines, cardiovascular and neurological drugs and others.
Executives
Tian Wen Shu Supervisors
Ai Ying Ping Director
Lei Qi Gang Executives
Hao Rui Zhi Directors, Directors, and Executives

Sinchuan Hezong Medicine Easy-to-buy Pharmaceutical Co (SZSE:300937) Headlines

No Headlines